The role of carbonic anhydrase IX overexpression in kidney cancer

European Journal of Cancer

Volumn 41, Issue 18, 2005, Pages 2935-2947

  Dorai, Thambi ^a   Sawczuk, Ihor S ^b,c   Pastorek, Jaromir ^d   Wiernik, Peter H ^a   Dutcher, Janice P ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^c College of Physicians and Surgeons ^*  (United States)

^d INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

Carbonic anhydrase IX; Carbonic anhydrase XII; Cell signaling; Clear cell; Epidermal growth factor receptor; Renal cell carcinoma

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CLEAR CELL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; HYPOXIA; KIDNEY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, NEOPLASM; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOPRECIPITATION; KIDNEY NEOPLASMS; MUTAGENESIS; PHOSPHORYLATION; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 28244451574     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.09.011     Document Type: Article

References (80)

1. L.M. Hock, J. Lynch, and K.C. Balaji Increasing incidence of all stages of kidney cancer in the last two decades in the United states: an analysis of surveillance, epidemiology and end results program data J Urol 167 2002 57 60
2. A. Jemal, T. Murray, and A. Samuels Cancer statistics 2003 CA-Cancer J Clin 52 2003 23 47
3. M. Takahashi, X.J. Yang, and J. Sugimura Molecular subclassification of kidney tumours and the discovery of new diagnostic markers Oncogene 22 2003 6810 6818
4. J.P. Higgins, R. Shinghal, and H. Gill Gene expression patterns in renal cell carcinoma assessed by complementary cDNA microarray Am J Pathol 162 2003 925 932
5. V.E. Reuter Jr., and J.C. Presti Contemporary approach to the classification of renal epithelial tumours Semin Oncol 27 2000 124 137
6. W.M. Linehan, and B. Zbar Focus on kidney cancer Cancer Cell 6 2004 223 228
7. J.M. McKiernan, R. Buttyan, and N.H. Bander Expression of the tumour associated gene MN: a potential biomarker for human renal cell carcinoma Cancer Res 57 1997 2362 2365
8. D.A. Whittington, A. Waheed, and B. Ulmasov Crystal structure of the dimeric extracellular domain of carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumour cells Proc Natl Acad Sci USA 98 2001 9545 9550
9. S. Parkkila, A.K. Parkkila, and J. Saarino Expression of membrane associated carbonic anhydrase XII in human kidney and renal tumours J Histochem Cytochem 48 2000 1601 1608
10. J. Saarino, S. Parkkila, and A.K. Parkkila Transmembrane carbonic anhydrase MN CA IX is a potential biomarker for biliary tumours J Hepatol 35 2001 643 649
11. J.R. Turner, R.D. Odze, and C.P. Crum MN antigen expression in normal, preneoplastic and neoplastic esophagus: a clinicopathological study of a new cancer associated biomarker Human Pathol 28 1997 740 744
12. A.J. Kivela, J. Saarnio, and T.J. Karttunen Differential expression of cytoplasmic carbonic anhydrases I, II and the membrane associated enzymes CA IX and CA XII in normal mucosa of large intestine and in colorectal tumours Dig Dis Sci 46 2001 2179 2186
13. A.J. Pantuck, G. Zeng, and A. Belldegrun Pathobiology, prognosis and targeted therapy for renal cell carcinoma exploiting hypoxia induced pathway Clin Cancer Res 9 2003 4641 4652
14. C. Potter, and A.L. Harris Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target Cell Cycle 3 2004 164 167
15. B.C. Tripp, K. Smith, and J.G. Ferry Carbonic anhydrase: new insights for an ancient enzyme J Biol Chem 276 2001 48615 48618
16. J. Pastorek, S. Pastorekova, and I. Gallebaut Cloning and characterization of MN, a tumour associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment Oncogene 9 1994 2877 2888
17. S. Parkkila An overview of the distribution and function of carbonic anhydrases in mammals W.R. Chegwidden N. Carter Y. Edwards The carbonic anhydrases: new horizons 2000 Birkhauser Verlag Basel, Switzerland 76 93
18. Y. Murakami, K. Kanda, and M. Tsuji MN/CA 9 gene expression as a potential biomarker in renal cell carcinoma BJU Int 83 1999 743 747
19. S. Ivanov, S.Y. Liao, and A. Ivanova Expression of hypoxia inducible cell surface transmembrane carbonic anhydrases in human cancer Am J Pathol 158 2001 905 919
20. Z. Zhuang, J.R. Gnarra, and C.F. Dudley Detection of von Hippel-Lindau gene mutations in paraffin embedded sporadic renal carcinoma specimens Mod Pathol 9 1999 838 842
21. S. Ashida, I. Nishimori, and M. Tanimura Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma J Cancer Res Clin Oncol 128 2002 561 568
22. S.Y. Liao, O.N. Aurelio, and K. Jan Identification of the MN/CA9 protein as a viable diagnostic biomarker of clear cell renal carcinoma of the kidney Cancer Res 57 1997 2827 2831
23. S.V. Ivanov, I. Kuzmin, and M.H. Wei Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes Proc Natl Acad Sci USA 95 1998 12596 12601
24. P.H. Maxwell, M.S. Wiesener, and G.W. Chang The tumour suppressor protein VHL targets hypoxia inducible factors for oxygen dependent proteolysis Nature 399 1999 271 275
25. 2 sensing Science 292 2001 464 468
26. 2 regulated prolyl hydroxylation Science 292 2001 468 472
27. J. Rohzim, M. Sameni, and G. Ziegler Pericellular pH affects distribution and secretion of cathepsin B in malignant cells Cancer Res 54 1994 6517 6525
28. Q. Shi, X. Le, and B. Wang Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells Oncogene 20 2001 3751 3756
29. A. Lardner The effects of extracellular pH on immune function J Leukoc Biol 69 2001 522 530
30. B.A. Teicher, S.D. Liu, and J.T. Liu Carbonic anhydrase inhibitor as potential modulator of cancer therapies Anti Cancer Res 13 1993 1549 1556
31. E. Svastova, N. Zieka, and M. Zatovicova Carbonic anhydrase IX reduces E-cadherin mediated adhesion of MDCK cells via interaction with β-catenin Exp Cell Res 290 2003 332 345
32. I.R.G. Beavon Regulation of E-cadherin: does hypoxia initiate a metastatic cascade? J Clin Pathol Mol Pathol 52 1999 179 187
33. T. Genda, M. Sakamoto, and T. Ichida Loss of cell-cell contact is induced by integrin-mediated cell substratum adhesion in highly motile and highly metastatic hepatocellular carcinoma cells Lab Invest 80 2000 387 394
34. P.J. Beltran, and J.L. Bixby Receptor protein tyrosine phosphatases as modulators of cellular adhesion Front Biosci 8 2003 287 299
35. G. Barnea, O. Silvennoinen, and B. Shaanan Identification of a carbonic anhydrase like domain in the extracellular region of RPTP-γ defines a new subfamily of receptor tyrosine phosphatases Mol Cell Biol 13 1993 1497 1506
36. E. Peles, M. Nativ, and P.L. Campbell The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin Cell 82 1995 251 260
37. C.P.S. Potter, and A.L. Harris Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer Brit J Cancer 89 2003 2 7
38. J. Goebel, K. Forrest, and D. Flynn Lipid rafts, major histocompatibility complex molecules and immune regulation Human Immunol 63 2002 813 820
39. M. Zatovicova, K. Tarabkova, and E. Svastova Monoclonal antibodies generated in carbonic anhydrase IX deficient mice recognise different domains of tumour associated hypoxia induced carbonic anhydrase IX J Immunol Meth 282 2003 117 134
40. J. Sun, M. Nanjundan, and L.J. Pike Plasma membrane phospholipid scramblase I is enriched in lipid rafts and interacts with the epidermal growth factor receptor Biochemistry 41 2002 6338 6345
41. J.E. Dancey Epidermal growth factor receptor and epidermal growth factor receptor therapies in renal cell carcinoma: do we need a better mouse trap? J Clin Oncol 22 2004 2975 2977
42. I. Vivanco, and C.L. Sawyers The phosphatidylinositol-3-Kinase-Akt pathway in human cancer Nat Rev Cancer 2 2002 489 501
43. B. Vanhaesebroeck, S.J. Leevers, and G. Panayotou Phosphoinositide 3 Kinases: a conserved family of signal transducers Trends Biochem Sci 22 1997 267 272
44. E. Svastova, A. Hulikova, and M. Rafajova Hypoxia activates the capacity of tumour associated carbonic anhydrase IX to acidify extracellular pH FEBS Lett 577 2004 439 445
45. N.J.P. Beasley, C.C. Wykoff, and P.H. Watson Carbonic anhydrase IX, an endogeneous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis and microvessel density Cancer Res 61 2001 5262 5267
46. P.L. Olive, C. Aquino-Parsons, and S.H. MacPhail Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer Cancer Res 61 2001 8924 8929
47. D.E. Richard, E. Berra, and J. Pouysegur Nonhypoxic pathway mediates the induction of hypoxia inducible factor 1-α in vascular smooth muscle cells J Biol Chem 275 2000 26765 26771
48. S. Kaluz, M. Kaluzova, and A. Chrastina Lowered oxygen tension induce s expression of hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia inducible factor 1-α stabilization: a role for phosphatidylinositol-3- Kinase Cancer Res 62 2002 4469 4477
49. R.D. Leek, R.J. Landers, and A.L. Harris Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast Brit J Cancer 79 1999 991 995
50. J.J. Haddad, and S.C. Land A non-hypoxic ROS-sensitive pathway mediates TNF-alpha dependent regulation of HIF-1α FEBS Lett 505 2001 269 274
51. C.C. Wykoff, N.J.P. Beasley, and P.H. Watson Hypoxia inducible expression of tumour associated carbonic anhydrases Cancer Res 60 2000 7075 7083
52. J.A. Loncaster, A.L. Harris, and S.E. Davidson Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker for hypoxia: correlations with tumour oxygen measurements and prognosis in locally advanced carcinoma of the cervix Cancer Res 61 2001 6394 6399
53. S.K. Chia, C.C. Wykoff, and P.H. Watson Prognostic significance of a novel hypoxia regulated marker, carbonic anhydrase IX in invasive breast carcinoma J Clin Oncol 19 2001 3660 3668
54. A. Giatromalonaki, M.I. Koukourakis, and E. Sivridis Expression of hypoxia inducible carbonic anhydrase 9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer Cancer Res 61 2001 7992 7998
55. H. Moch, G. Sauter, and N. Buchholz Epidermal growth factor receptor expression is associated with rapid tumour cell proliferation in renal cell carcinoma Human Pathol 28 1997 1255 1259
56. D.L. Uhlman, P. Nguyen, and J.C. Manivel Epidermal growth factor receptor and transforming growth factor α expression in papillary and non-papillary renal cell carcinoma: correlation with metastatic behavior and prognosis Clin Cancer Res 1 1995 913 920
57. U. Ramp, K. Jaquet, and P. Reinecke Functional intactness of stimulatory and inhibitory autocrine loops in human renal cell carcinoma cell lines of the clear cell type J Urol 157 1997 2345 2350
58. M. Nanjundan, J. Sun, and J. Zhao Plasma membrane phospholipids scramblase 1 promotes EGF-dependent activation of c-src through the epidermal growth factor receptor J Biol Chem 278 2003 37413 37418
59. X. Chen, and M.D. Resh Cholesterol depletion from plasma membrane triggers ligand independent activation of the epidermal growth factor receptor J Biol Chem 277 2002 49631 49637
60. J. Schlessinger Cell signalling by receptor tyrosine kinases Cell 103 2000 211 225
61. Y. Yarden, and M.Y. Sliwkowski Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2001 127 137
62. T. Rordorf-Nikolic, D.J. Van Horn, and D. Chen Regulation of phosphatidylinositol 3'kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit J Biol Chem 270 1995 3662 3666
63. N.J. Hellyer, K. Cheng, and J.G. Koland ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-Kinase Biochem J 333 1998 757 763
64. C. Ponzetto, A. Bardelli, and F. Maina A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor Mol Cell Biol 13 1993 4600 4608
65. H. Wu, D.A. Windmiller, and L. Wang YXXM motifs in the PDGF-beta receptor serve dual roles as phosphoinositide 3-kinase binding motifs and tyrosine based endocytic sorting signals J Biol Chem 278 2003 40425 40428
66. A. Sekulic A direct linkage between the phosphatidide-3-kinase-AKT signalling pathway and the mammalian target of rapamycin in mitogen stimulated and transformed cells Cancer Res 60 2000 3504 3513
67. S.C. Kozma, and G. Thomas Regulation of cell size in growth, development and human disease: role of PI-3K, PKB and S6K BioEssays 24 2002 65 71
68. P.K. Vogt PI-3-Kinase, mTOR, protein synthesis and cancer Trends Mol Med 7 2001 482 484
69. M. Aoki, E. Blazek, and P.K. Vogt A role of the kinase mTOR in cellular transformation induced by the oncoproteins PI-3K and AKT Proc Natl Acad Sci USA 98 2001 136 141
70. M.A. Bjornsti, and P.J. Houghton The mTOR pathway: a target for cancer therapy Nat Rev Cancer 4 2004 335 348
71. R.T. Abraham Identification of TOR signalling complexes: more TORC for the cell growth engine Cell 111 2002 9 12
72. E.L. Page, G.A. Robitaille, and J. Pouyssegur Induction of hypoxia inducible factor 1-α by transcriptional and translational mechanisms J Biol Chem 277 2002 48403 48409
73. C.C. Hudson, M. Liu, and G.G. Chiang Regulation of hypoxia inducible factor 1-α expression and function by the mammalian target of rapamycin Mol Cell Biol 22 2002 7004 7014
74. R.J. Philips, J. Mestas, and M. Ghareee-Kermani Epidermal growth factor and hypoxia induced expression of CXC chemokine receptor 4 in non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-Kinase/PTEN/AKT/ mammalian target of rapamycin signalling pathway and the activation of hypoxia inducible factor 1-alpha J Biol Chem 280 2005 22473 22481
75. D. Sterling, B.V. Alvarez, and J.R. Casey The extracellular component of a transport metabolon: extracellular loop 4 of the human AE1 C1-/HCO3-exchanger binds to carbonic anhydrase IV J Biol Chem 277 2002 25239 25246
76. K. Mekhail, L. Gunaratnam, and M.E. Bonicalzi HIF activation by pH dependent nucleolar sequestration of VHL Nat Cell Biol 6 2004 642 647
77. A.D. Perera, E.V. Kleymenova, and C.L. Walker Requirement for the von Hippel-Lindau tumour suppressor gene for functional epidermal growth factor receptor blockade by monoclonal antibody C225 in renal cell carcinoma Clin Cancer Res 6 2000 1518 1523
78. B. Knebelmann, S. Ananth, and H.T. Cohen Transforming growth factor α is a target for the von Hippel-Lindau tumour suppressor Cancer Res 58 1998 226 231
79. S. Pal, K.P. Claffey, and K.H.F. Dvora The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways J Biol Chem 272 1997 27509 27512
80. Y. Kawakami, H. Nishimato, and J. Kitaura Protein Kinase C beta II regulates Akt phosphorylation on ser 473 in a cell type and stimulus specific fashion J Biol Chem 279 2004 47720 47725